Cauldron Ferm has turned microbes into nonstop assembly lines

Cauldron Ferm's journey as a startup is anything but conventional, rooted in a vision that dates back to the 1960s or possibly the 1970s. Co-founders David and Polly McLennan aspired to tackle global hunger by cultivating protein through microbial processes. However, they faced significant challenges, particularly the costly and time-consuming nature of traditional fermentation methods. Typically, fermentation occurs in batches, reminiscent of a brewery's production cycle. Ingredients are introduced, and microbes go to work until the process halts for product extraction. While this model is viable for alcohol production, where prices are high, food production demands a more economical approach. Determined to make a difference, the McLennans dedicated 40 years to refining their continuous fermentation technology, evolving it into a system where microbes function as perpetual assembly lines, generating products without interruption. Michele Stansfield, who joined the company in 2012, reflected on the initial underestimation of their potential. "We didn’t understand the challenge of continuous fermentation for synthetic biology," she noted. Recognizing the opportunity, she pivoted the company from a modest service provider to a dynamic startup. Under her leadership, Cauldron Ferm secured $13.25 million in a Series A2 funding round, led by Main Sequence Ventures and joined by Horizons Ventures, NGS Super, and SOSV. This new influx of capital follows a previous $6.5 million raised in 2024. Stansfield emphasized that the funding aims to enhance the company's technological edge. The firm's innovative approach, termed "hyper fermentation," enables microbes to remain in their most productive state. This technique can be adapted to existing batch fermentation systems with minor adjustments. Clients provide their own microbial strains, while Cauldron Ferm optimizes growth conditions, including nutrient management. Currently, the company focuses on producing fats and proteins, such as whey protein, which can seamlessly integrate into existing supply chains. However, Stansfield hinted at broader ambitions: "Sixty percent of all inputs to the global economy can be produced from biology. Food was where we started, but now we’re beginning to diversify significantly."